Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's Syndrome
Status:
Unknown status
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
Past literature showed encouraging effects of mycophenolate on dryness symptoms and quality
of life in patients with Sjogren's syndrome. Mycophenolate also has excellent
immunomodulation effects in lupus nephritis. Currently Mycophenolate is only used in lupus
nephritis and organ transplant. It is unknown whether low dosage of mycophenolate mofetil
could be used to improve ocular dryness and oral dryness in patients with Sjogren's syndrome.